Skip to main content
. 2025 Oct 5;20:12117–12175. doi: 10.2147/IJN.S550390

Table 8.

Molecular Mechanism of hucMSCs-EVs in Treating Different Diseases in the Urinary System

HucMSCs-EVs Cargo Target/Signaling Conditions/Diseases Actiona Reference
miR-23a-3p KLF3, STAT3 DKD Renal fibrosis↓, inflammation↓ [324]
miR-22-3p NLRP3 DKD Inflammatory cytokine↓, protect podocytes [325]
miR-874-3p RIPK1/PGAM5 AKI Mitochondrial fission↓, necroptosis↓ [326]
miR-100-5p FKBP5, AKT AKI Tubular apoptosis↓ [327]
None reported NLRP3, caspase-1, gasdermin D AKI Pyroptosis↓, inflammation↓ [328]
miR-13896 TRAF6/NF-κB AKI M2 polarization↑, inflammation↓ [329]
CK1δ, β-TRCP YAP Renal fibrosis Collagen degradation↓ [330]
miR-13474 ADAM17/Notch1/TGF-β/Smad Renal fibrosis Fibrosis↓ [331]
miR-146b IRAK1/NF-κB AKI Inflammation↓ [332]
miR-148b-3p PDK4/ATF-6 AKI Endoplasmic reticulum stress↓ [334]
None reported Lamin A/C, p53-p21 Renal aging Cellular senescence↓ [335]
lncRNA FAM99B IL-6/STAT3/IL-17 Lupus nephritis Th1/Th17/Treg balance↑ [336]
miR-375 HDAC4 AKI Autophagy↑, T cell survival↑ [337]
miR-146a TRAF6, IRAK1, NF-κB Urethral stricture Fibrosis↓ [341]
miR-15a-5p SEPT2 WT The proliferation, migration, and invasion of tumor cells↓, apoptosis↑ [342]

Notes: a ↑ indicates promotion or upregulation; ↓ indicates inhibition or downregulation. Molecular mechanism of hucMSCs-EVs in treating different diseases in the reproductive system.